본문으로 건너뛰기
← 뒤로

The association of the second-to-fourth digit ratio with prostate cancer diagnosed by magnetic resonance imaging-transrectal ultrasound fusion biopsy: A comparative analytical cross-sectional analysis of prospectively recorded data.

단면연구 1/5 보강
Medicine 📖 저널 OA 98.4% 2021: 23/23 OA 2022: 25/25 OA 2023: 59/59 OA 2024: 58/58 OA 2025: 274/285 OA 2026: 186/186 OA 2021~2026 2025 Vol.104(40) p. e44502
Retraction 확인
출처

Erbin A, Dizdaroglu C, Erdal FS, Sekkeli S, Meric A, Turkay R

📝 환자 설명용 한 줄

Only a few studies that employed conventional transrectal ultrasound (TRUS) biopsy have investigated the connection between the second digit (2D)-to-fourth digit (4D) ratio and prostate cancer (PCa),

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 168

이 논문을 인용하기

↓ .bib ↓ .ris
APA Erbin A, Dizdaroglu C, et al. (2025). The association of the second-to-fourth digit ratio with prostate cancer diagnosed by magnetic resonance imaging-transrectal ultrasound fusion biopsy: A comparative analytical cross-sectional analysis of prospectively recorded data.. Medicine, 104(40), e44502. https://doi.org/10.1097/MD.0000000000044502
MLA Erbin A, et al.. "The association of the second-to-fourth digit ratio with prostate cancer diagnosed by magnetic resonance imaging-transrectal ultrasound fusion biopsy: A comparative analytical cross-sectional analysis of prospectively recorded data.." Medicine, vol. 104, no. 40, 2025, pp. e44502.
PMID 41054063 ↗

Abstract

Only a few studies that employed conventional transrectal ultrasound (TRUS) biopsy have investigated the connection between the second digit (2D)-to-fourth digit (4D) ratio and prostate cancer (PCa), and their findings have been conflicting. We aimed to investigate the correlation between the 2D:4D ratio and prostate cancer, identified through a multiparametric magnetic resonance imaging-TRUS fusion biopsy, and its association with clinically significant PCa (csPCa). Patients who underwent multiparametric magnetic resonance imaging/TRUS fusion biopsy due to the prostate imaging reporting and data system 3/4/5 lesions between 2020 and 2024 were included in the study. The patients were divided into 3 groups: study group (n = 168): prostate cancer; study subgroup: csPCa (n = 95); and control group (n = 360): non-cancer. The groups were compared in terms of demographic data, patient characteristics, MRI characteristics, pathological features, cancer stages, and the right-hand 2D:4D ratio. There was a significant difference between the study and control groups for total prostate-specific antigen (PSA) levels, the rate of positive digital rectal examination findings, PSA density, and prostate volume, all favoring the study group (<.001, <.001, <.001, and <.001, respectively). The study and control groups did not show any difference in terms of right-hand 2D:4D ratio. Similarly, no difference was observed between the study subgroup and the control group when the study group was evaluated specifically for csPCa. In a multivariable regression analysis, age and PSA were found to be independent risk factors; prostate volume and the 2D:4D ratio were not significant after adjustment for other variables. The 2D:4D ratio may not be a dependable predictor for both overall and csPCa risk. Considering the literature data and the results of our study, there is an unclear relationship between the 2D:4D ratio and PCa.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (1)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기